نتائج البحث - "Cecilia Linde"

1

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial

المؤلفون: Cecilia Linde, Gianluigi Savarese, Camilla Hage, Emmanuel Oger, Lars H. Lund, Erwan Donal, Ashwin Venkateshvaran, Anna Lundberg, Lina Benson, Jean-Claude Daubert

المساهمون: Karolinska Institute, Karolinska University Hospital [Stockholm], Novartis Pharmaceutical Corporation, Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Federation Francaise de Cardiologie/Societe Francaise de Cardiologie, France, Medtronic Bakken Research Center, Maastricht, the Netherlands MedtronicNetherlands Government, Novartis Novartis, Swedish Research Council (Vetenskapsrade) Swedish Research Council [20180899], Jonchère, Laurent, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: ESC Heart Failure
ESC Heart Failure, 2022, 9 (1), pp.164-177. ⟨10.1002/ehf2.13705⟩
Esc Heart Failure
Esc Heart Failure, 2021, ⟨10.1002/ehf2.13705⟩
ESC Heart Failure, Wiley, 2021, ⟨10.1002/ehf2.13705⟩
ESC Heart Failure, Vol 9, Iss 1, Pp 164-177 (2022)

مصطلحات موضوعية: Male, 030204 cardiovascular system & hematology, Left ventricular hypertrophy, Ventricular Function, Left, Sacubitril, 0302 clinical medicine, Left atrial enlargement, Heart failure with borderline ejection fraction, Medicine, 030212 general & internal medicine, Structural heart disease, Aged, 80 and over, Eligibility, Clinical Trials as Topic, Ejection fraction, Aminobutyrates, Heart failure with mid-range ejection fraction, 3. Good health, Heart failure with preserved ejection fraction, Valsartan, Echocardiography, Cardiology, cardiovascular system, Female, Original Article, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Cardiology and Cardiovascular Medicine, circulatory and respiratory physiology, medicine.drug, Heart failure with mildly reduced ejection fraction, Trial design, medicine.medical_specialty, PARAGON‐HF, Angiotensin Receptor Antagonists, 03 medical and health sciences, Internal medicine, Humans, Diseases of the circulatory (Cardiovascular) system, cardiovascular diseases, Sacubitril/valsartan, Aged, Heart Failure, [SDV.IB] Life Sciences [q-bio]/Bioengineering, business.industry, Biphenyl Compounds, PARAGON-HF, Stroke Volume, Original Articles, Heart failure with mid‐range ejection fraction, medicine.disease, RC666-701, Heart failure, business, Sacubitril, Valsartan

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a59787e8a640cda6080a4b6496ce040Test
https://hal.science/hal-03463825/documentTest

2

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure

المؤلفون: Lars H. Lund, Michael Melin, Alicia Uijl, Lina Benson, Gianluigi Savarese, Cecilia Linde, B. Schrage, Ulf Dahlström, Frieder Braunschweig

المصدر: Europace

مصطلحات موضوعية: Male, medicine.medical_specialty, genetic structures, medicine.medical_treatment, Cardiac resynchronization therapy, Swedish Heart Failure Registry, Implantable cardioverter-defibrillator, Ventricular Dysfunction, Left, Pacing and Cardiac Resynchronization Therapy, Risk Factors, Physiology (medical), Internal medicine, Medicine, Outpatient clinic, Humans, AcademicSubjects/MED00200, Cardiac and Cardiovascular Systems, cardiovascular diseases, Aged, Heart Failure, Ejection fraction, Primary prevention, Kardiologi, business.industry, Proportional hazards model, Hazard ratio, Stroke Volume, medicine.disease, Heart failure with reduced ejection fraction, equipment and supplies, Defibrillators, Implantable, Treatment Outcome, Heart failure, Cohort, Cinical Research, cardiovascular system, Female, Cardiology and Cardiovascular Medicine, business, circulatory and respiratory physiology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c854d6fdb75e8302c7d36799030f82c0Test
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-182649Test

3

CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy—an Irish subset analysis

المؤلفون: Kenneth Dickstein, Camilla Normand, Theodore Murphy, Deepti Ranganathan, Nial Mahon, Conor R Sheahan, R Sheahan, Zain Sharif, Cecilia Linde

المصدر: Irish Journal of Medical Science (1971 -). 189:895-905

مصطلحات موضوعية: Male, medicine.medical_specialty, medicine.medical_treatment, Mean QRS Duration, Cardiac resynchronization therapy, 030204 cardiovascular system & hematology, Cardiac Resynchronization Therapy, 03 medical and health sciences, QRS complex, 0302 clinical medicine, Surveys and Questionnaires, Internal medicine, medicine, Humans, Sinus rhythm, Cardiac Resynchronization Therapy Devices, cardiovascular diseases, 030212 general & internal medicine, Aged, Ejection fraction, Left bundle branch block, business.industry, Atrial fibrillation, General Medicine, medicine.disease, Europe, Heart failure, cardiovascular system, Cardiology, Female, business, Ireland, circulatory and respiratory physiology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f51596e8168edf83c16f4bc522e65ea7Test
https://doi.org/10.1007/s11845-020-02173-yTest

4

The European Society of Cardiology Cardiac Resynchronization Therapy Survey II A comparison of cardiac resynchronization therapy implantation practice in Europe and France

المؤلفون: Jean-Claude Deharo, Cecilia Linde, Serge Boveda, Jacques Mansourati, Philippe Rumeau, Pascal Defaye, Jerome Horvilleur, Pascal Sagnol, Salem Younsi, Nicolas Lellouche, Camilla Normand, Mathieu Steinbach, Antoine Da Costa, Vincent Galand, Kenneth Dickstein, Christophe Leclercq, Paul Bru, Thierry Beard

المساهمون: Laboratoire Traitement du Signal et de l'Image (LTSI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Karolinska University Hospital [Stockholm], Hôpital de la Cavale Blanche - CHRU Brest (CHU - BREST ), CHU Marseille, Centre Hospitalier Chalon-sur-Saône William Morey, Clinique Pasteur, Clinique Pasteur [Toulouse], University of Stavanger, University of Bergen (UiB), CHU Pontchaillou [Rennes], Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), CCSD, Accord Elsevier, Clinical sciences

المصدر: Archives of cardiovascular diseases
Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2019, 112 (11), pp.713-722. ⟨10.1016/j.acvd.2019.09.005⟩
Archives of cardiovascular diseases, 2019, 112 (11), pp.713-722. ⟨10.1016/j.acvd.2019.09.005⟩

مصطلحات موضوعية: Male, Time Factors, genetic structures, medicine.medical_treatment, Comorbidity, 030204 cardiovascular system & hematology, Ventricular Function, Left, French population, Heart Failure/diagnosis, 0302 clinical medicine, 030212 general & internal medicine, Practice Patterns, Physicians', Survey, Aged, 80 and over, Cardiac resynchronization therapy, Ejection fraction, Guideline adherence, General Medicine, Middle Aged, Clinical Practice, Europe, Treatment Outcome, Registre, Healthcare Disparities/trends, cardiovascular system, Female, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Cardiology and Cardiovascular Medicine, circulatory and respiratory physiology, medicine.medical_specialty, Population européennes, Heart failure, 03 medical and health sciences, medicine, Population française, Humans, In patient, Cardiac Resynchronization Therapy Devices/trends, Implantation procedure, Cardiac Resynchronization Therapy Devices, cardiovascular diseases, Healthcare Disparities, Aged, [SDV.IB] Life Sciences [q-bio]/Bioengineering, business.industry, Patient Selection, Europe population, Stroke Volume, European population, Recovery of Function, medicine.disease, Practice Patterns, Physicians'/trends, Insuffisance cardiaque, Health Care Surveys, Emergency medicine, Cardiac Resynchronization Therapy/adverse effects, business